Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected children

Journal of Medical Virology

Volumn 55, Issue 1, 1998, Pages 56-63

  Fitzgibbon, Joseph E ^a,b   Gaur, Sunanda ^a   Gavai, Medha ^a   Gregory, Patrice ^a   Frenkel, Lawrence D ^a   John Jr , Joseph F ^a  

^a Dent New Jersey/Robert Wood J   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Pathogenesis; Pediatrics; Virulence

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SYNCYTIUM; T LYMPHOCYTE; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS ISOLATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; GIANT CELLS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INFANT; LONGITUDINAL STUDIES; PHENOTYPE; RETROSPECTIVE STUDIES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031860073     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199805)55:1<56::AID-JMV10>3.0.CO;2-Y     Document Type: Article

References (27)

1. Adachi A, Gendelman H, Koenig S, Folks T, Willey R, Rabson A, Martin MA (1986): Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. Journal of Virology 59: 284-291.
2. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA (1996): CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272(5270):1955-1958.
3. Asjo B, Morfeldt-Manson L, Albert J, Biberfeld G, Karlsson A, Lipman K, Fenyo EM (1986): Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2(8508):660-662.
4. Boucher C, Lange JMA, Miedema FF, Weverling GJ, Koot M, Mulder JW, Goudsmit J, Kellam P, Larder BA, Tersmette M (1992): HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS 6:1259-1264.
5. Bozzette S, McCutchan JA, Spector SA, Wright B, Richman D (1993): A cross-sectional comparison of persons with syncytium-and non-syncytium-inducing human immunodeficiency virus. Journal of Infectious Diseases 168:1374-1379.
6. Caldwell MB, Oxtoby MJ, Simonds RJ, Lindegren ML, Rogers MF (1994): 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. Morbidity and Mortality Weekly Report 43(RR-12):1-10.
7. De Rossi A, Giaquinto C, Ometto L, Mammamo F, Zannotto C, Dunn D, Cheico-Bianchi L (1993): Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. Journal of Pediatrics 123:929-936.
8. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, Landau NR (1996): Identification of a major co-receptor for primary isolates of HIV-1. Nature 381(6584): 661-666.
9. Denny T, Yogev R, Gelman R, Skuza C, Oleske J, Chadwick E, Cheng S-C, Connor E (1992): Lymphocyte subsets in healthy children during the first 5 years of life. Journal of the American Medical Association 267(11):1484-1488.
10. Evans LA, McHugh TM, Stites DP, Levy JA (1987): Differential ability of HIV isolates to productively infect human cells. Journal of Immunology 138:3415-3418.
11. Feigin RD, Matson DO (1992): Opportunistic infections. In Feigin RD, Cherry JD (eds): "Textbook of Pediatric Infectious Diseases. 3rd Edition," Vol. I, Philadelphia, PA: WB Saunders Company, pp. 960-989.
12. Fouchier RAM, Groenink M, Kootstra NA, Tersmette M, Huisman HG, Miedema F, Schuitemaker H (1992): Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Journal of Virology 66:3183-3187.
13. Gupta P, Urbach A, Cosentino L, Thampatty P, Brady M (1993): HIV-1 isolates from children with or without AIDS have similar in vitro biologic properties. AIDS 7:1561-1564.
14. Harada S, Koyanagi Y, Yamamoto N (1985): Infection of HTLV-III/ LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229(4713):563-566.
15. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995): Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373(6510):123-126.
16. Hollinger FB, Bremer JW, Myers LE, Gold JWM, McQuay L, Laboratories T.N.N.D.A.V. (1992): Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. Journal of Clinical Microbiology 30:1787-1794.
17. Japour A, Fiscus S, Arduino J-M, Mayers D, Reichelderfer P, Kuritzkes D (1994): Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. Journal of Clinical Microbiology 32: 2291-2294.
18. Karlsson A, Parsmyer K, Sandstrom E, Fenyo E-M, Albert J (1994): MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. Journal of Clinical Microbiology 32:364-370.
19. Koot M, Keet IPM, Vos AHV, de Goede REY, Roos MTL, Coutinho RA, Miedema F, Schellekens PTA, Tersmette M (1993a): Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Annals of Internal Medicine 118:681-688.
20. Koot M, Schellekens PTA, Mulder JW, Lange JMA, Roos MTL, Coutinho RA, Tersmette M, Miedema F (1993b): Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine. Journal of Infectious Diseases 168:733-736.
21. Mammano F, Salvatori F, Ometto L, Panozzo M, Cheico-Bianchi L, De Rossi A (1995): Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1. Journal of Virology 69:82-92.
22. Richman DD, Bozzette SA (1994): The impact of the syncytium -inducing phenotype of human immunodeficiency virus on disease progression. Journal of Infectious Diseases 169:968-974.
23. Spencer LT, Ogino MT, Dankner WM, Spector SA (1994): Clinical significance of human immunodeficiency virus Type 1 phenotypes in infected children. Journal of Infectious Diseases 169:491-495.
24. Tersmette M, De Goede REY, Al BJM, Winkel IN, Gruters RA, Cuypers HT, Huisman HG, Miedema F (1988): Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AID) and AIDS-related complex. Journal of Virology 62:2026-2032.
25. Tersmette M, Lange JMA, DeGoede RWY, DeWolf F, Eeftink-Schnattenkerk JKM, Schellekens PTA, Coutinho RA, Huisman JG, Goudsmit J, Miedema F (1989): Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet 983-985.
26. Wei XP, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM (1995): Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373(6510):117-122.
27. Willey RL, Smith DH, Lasky LA, Theodore TS, Earl PL, Moss B, Capon DJ, Martin MA (1988): In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. Journal of Virology 62:139-147.